Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vir Biotechnology (VIR)
NASDAQ:VIR
Vir Biotechnology (VIR) Ownership Overview
13.77% Insiders
13.16% Mutual Funds
22.30% Other Institutional Investors
21.33% ETFs
29.44% Public Companies and Individual Investors
The ownership structure of Vir Biotechnology (VIR) stock is a mix of institutional, retail, and individual investors. Approximately 56.79% of the company’s stock is owned by Institutional Investors, 13.77% is owned by Insiders, and 29.44% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Feb 19, 2025 | George Scangos Director | xxxxxxxxxxxxx | $107557 |
| Dec 04, 2024 | Vanina De Verneuil Evp & Gc | xxxxxxxxxxxxx | $625 |
| Nov 05, 2024 | Vanina De Verneuil Evp & Gc | xxxxxxxxxxxxx | $10102 |
| Jun 12, 2024 | Saira Ramasastry Director | xxxxxxxxxxxxx | $43760 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 13,534,704 | Insider | 9.83% | 130,609,894 | |
| 11,654,358 | Institution | 8.46% | 112,464,555 | |
| 10,519,053 | Institution | 7.64% | 101,508,861 | |
| 9,137,461 | Institution | 6.63% | 88,176,499 | |
| 3,026,690 | Institution | 2.20% | 29,207,559 | |
| 2,084,548 | Insider | 1.51% | 20,115,888 | |
| 1,312,391 | Insider | 0.95% | 12,664,573 | |
| 1,037,132 | Institution | 0.75% | 10,008,324 | |
| 1,016,077 | Institution | 0.74% | 9,805,143 | |
| 914,071 | Institution | 0.66% | 8,820,785 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 9,137,461 | Institution | 6.63% | 88,176,499 | |
| 1,016,077 | Institution | 0.74% | 9,805,143 | |
| 914,071 | Institution | 0.66% | 8,820,785 | |
| 901,518 | Institution | 0.65% | 8,699,649 | |
| 661,624 | Institution | 0.48% | 6,384,672 | |
| 518,218 | Institution | 0.38% | 5,000,804 | |
| 490,242 | Institution | 0.36% | 4,730,835 | |
| 487,024 | Institution | 0.35% | 4,699,782 | |
| 460,198 | Institution | 0.33% | 4,440,911 | |
| 409,998 | Institution | 0.30% | 3,956,481 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,897,519 | Institution | 4.28% | 56,498,232 | |
| 3,440,500 | Institution | 2.50% | 25,253,270 | |
| 2,805,740 | Institution | 2.04% | 20,594,132 | |
| 2,409,477 | Institution | 1.75% | 23,251,453 | |
| 1,585,552 | Institution | 1.15% | 11,637,952 | |
| 1,358,854 | Institution | 0.99% | 9,973,988 | |
| 1,292,332 | Institution | 0.94% | 12,380,541 | |
| 1,040,832 | Institution | 0.76% | 9,971,171 | |
| 839,114 | Institution | 0.61% | 8,097,450 | |
| 835,774 | Institution | 0.61% | 8,006,715 |
FAQ
Who Owns Vir Biotechnology (VIR)?
According to the latest TipRanks data, approximately 22.30% of the company's stock is held by institutional investors, 13.77% is held by insiders, and 29.44% is held by retail investors.
What percentage of Vir Biotechnology (VIR) stock is held by institutional investors?
According to the latest TipRanks data, approximately 22.30% of Vir Biotechnology (VIR) stock is held by institutional investors.
What percentage of Vir Biotechnology (VIR) stock is held by retail investors?
According to the latest TipRanks data, approximately 29.44% of Vir Biotechnology (VIR) stock is held by retail investors.
Who owns the most shares of Vir Biotechnology (VIR)?
Robert Nelsen owns the most shares of Vir Biotechnology (VIR).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.